Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle - 29/08/11
, Jean Meynadier, MD b, Mohsen Alirezai, MD b, Sheru A George, MD, FRCP c, Ian Coutts, MD, MRCP c, Diane I Roseeuw, MD, PhD d, Jean Pierre Hachem, MD d, Philippe Briantais, MSc e, Farzaneh Sidou, PhD e, Pascale Soto, MRPharmS eAbstract |
This multicenter, randomized, investigator-blinded study compared the efficacy and tolerability of a combination of lymecycline 300 mg/day orally and adapalene topical gel 0.1% (n = 118) to lymecycline 300 mg/day orally plus vehicle gel (n = 124) in patients with moderate to moderately severe acne vulgaris with both inflammatory and noninflammatory lesions. The primary efficacy end point, total lesion count at end point (last observation carried forward), showed a statistically significant difference in favor of the lymecycline plus adapalene group (P = .0011). The mean decrease in total, inflammatory and noninflammatory lesion counts was significantly greater at end point in the lymecycline plus adapalene group than in the lymecycline plus vehicle group (P < .01). In addition, a significant difference for inflammatory and total acne lesions was seen sooner in the adapalene plus lymecycline group. In total, 75.5% of patients in the lymecycline plus adapalene group were markedly improved, almost clear or clear of their lesions at week 12, compared with 51.8% of those in the lymecycline plus vehicle group (P < .001). Local cutaneous tolerance was generally good in both groups, although more patients receiving the lymecycline plus adapalene combination experienced cutaneous reactions than those receiving lymecycline plus vehicle. There are relatively few studies comparing the efficacy of combined oral and topical therapy with either individual therapy alone. This study clearly demonstrates that lymecycline plus adapalene combination treatment resulted in a significantly greater mean decrease in the number of inflammatory, noninflammatory and total lesions than lymecycline plus vehicle and was well tolerated.
Le texte complet de cet article est disponible en PDF.Plan
 | This article is part of a supplement supported by an educational grant from Galderma International. Funding source: Galderma International funded the research reported here. |
Vol 49 - N° 3S
P. S218-S226 - septembre 2003 Retour au numéro
Article précédent
- Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
- John E Wolf, David Kaplan, Stephen J Kraus, Keith H Loven, Toivo Rist, Leonard J Swinyer, Michael D Baker, Yin S Liu, Janusz Czernielewski
- Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents
- Barbara Brand, Richard Gilbert, Michael D Baker, Michel Poncet, Alan Greenspan, Kathleen Georgeian, Andrew-Marc Soloff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?